NurExone Biologic's market cap is currently C$59.34M. The company's EPS TTM is C$-0.03369153984; its P/E ratio is ―; NurExone Biologic is scheduled to report earnings on August 27, 2025, and the estimated EPS forecast is C$-0.03. See an overview of income statement, balance sheet, and cash flow financials.
